A study to determine postoperative complication rates among Crohn's disease patients by biologic exposure
Latest Information Update: 21 Dec 2020
At a glance
- Drugs Anti-TNF monoclonal antibodies (Primary) ; Ustekinumab (Primary) ; Vedolizumab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions
- 21 Dec 2020 New trial record
- 28 Oct 2020 Results presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2020